2 studies found for:    LY2940680 | Open Studies
Show Display Options
Rank Status Study
1 Not yet recruiting A Phase 1B/2 Study of LY2940680 in Combination With Weekly Paclitaxel, Carboplatin, and Radiation in Localized Adenocarcinoma of the Esophagus or Gastroesophageal Junction
Condition: Esophageal Cancer
Interventions: Drug: LY2940680;   Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: Radiation Therapy;   Procedure: Endoscopy
2 Recruiting A Study of LY2940680 in Japanese Participants With Advanced Cancers
Condition: Neoplasm Metastasis
Intervention: Drug: LY2940680

Indicates status has not been verified in more than two years